氨曲南治疗下呼吸道感染疗效分析.pdfVIP

304 2009 7 11 7　M edical Pharmaceutical W rld , July 2009 V l 11 N . 7 【论著】 1 1 2 范照冬 ,王金柱 ,孔祥臣 　　【】　: 。: 90 45。 2. 0 g、2. 0 g , 12 h 1, 7～ 14 d。 、。: 91. 11% 86. 67% , 93. 33%、 89. 13% ,(P 0. 05) ;。: 、。 【】　 /; /; /; [ ]; 【】　 560. 53　　　　【】　 　　　　【】　 1008-69 19( 2009) 07-0304-02 R A Clinical Observation of Aztreonam in Treatment of Lower Respiratory Tract Infection - , - , - FAN Zha d ng WAN G Jin zhu KONG Xiang chen (J iaozuo M edical College f or Continuing Ed ucation , J iaozuo 454 100,China) 　　【Abstract】　Objective: T evaluate the efficacy and safety f aztre nam in the t reatment f l w er respirat ry t ract . : 90 ( infecti n Methods A t tal f cases w ere rand mly divided int aztre nam gr up and ceftazidime gr up each gr up have 45 patients ) . Tw gr ups w ere c mpared with the clinical efficacy , bacterial clearance rate and adverse circumstances. Results: Th e clinical efficacy rates f azt re nam gr up and cef tazidime gr up were 9 1. 11 percent and 86. 67 percent, th e bacterial clearance rates w ere 93. 33 percent and 89. 13 percent, th ere w ere n significant difference ( 0. 05) ; . : betw een tw gr ups P the tw gr ups w ere n t seri us adverse reacti ns Conclusion Aztr enam is an effective and safe f r clinical treatment f l w er respirat ry t ract infecti n. 【MeS 】　 Respirat ry Tract r Infecti n /drug therapy; Aztre nam /therapeutic use; Anti-Bacterial Agents/